Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins., PMID:15583133
Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells., PMID:16103144
Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome., PMID:16249071
Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion., PMID:17307213
Viral reactivation is not related to septic complications after major surgical resections., PMID:18397464
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa., PMID:19774687
Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8., PMID:19920174
Infection of porcine cells with human herpesviruses., PMID:20692426
Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody., PMID:21149698
Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus., PMID:21593154
Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL., PMID:21957301
Herpes virus fusion and entry: a story with many characters., PMID:22754650
The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation., PMID:25506120
Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism., PMID:26085146
Crystal Structure of the Human Cytomegalovirus Glycoprotein B., PMID:26484870
Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL., PMID:26656708
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination., PMID:27096949
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350., PMID:27291087
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome., PMID:27878471
Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice., PMID:27926486
Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies., PMID:28939750
Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry., PMID:29292383
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus., PMID:29669253
Acidic pH Mediates Changes in Antigenic and Oligomeric Conformation of Herpes Simplex Virus gB and Is a Determinant of Cell-Specific Entry., PMID:29925660
Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology., PMID:30727744
Epstein-Barr virus infection with acute acalculous cholecystitis in previously healthy children., PMID:31243873
Predictors of Epstein-Barr virus serostatus in young people in England., PMID:31779585
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits., PMID:32268575
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma., PMID:33268566
Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients., PMID:33493797
Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge., PMID:33808755
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042
Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses., PMID:35404082
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective., PMID:35493498
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells., PMID:35711430
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion., PMID:35917353
Urgency and necessity of Epstein-Barr virus prophylactic vaccines., PMID:36494369
Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma., PMID:36519117
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV., PMID:37848029
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice., PMID:38201224
Evaluation of serum Epstein-Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases., PMID:38587217
Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled Trial., PMID:38830139
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection., PMID:38906867
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy., PMID:38921797
GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection., PMID:39020055
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice., PMID:39346922
An insect cell-derived extracellular vesicle-based gB vaccine elicits robust adaptive immune responses against Epstein-Barr virus., PMID:39499444
A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection In Vitro and In Vivo., PMID:40272901
Structure and Antigenicity of Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein B., PMID:40285648
A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection., PMID:40338258
Relationships among hemocytes, tunic cells, germ cells, and accessory cells in the colonial ascidian Botryllus schlosseri. PMID: 21246708
Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. PMID: 1871041
Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue. PMID: 1724082
Encapsulated Mixture of Methyl Salicylate and Tributyrin Modulates Intestinal Microbiota and Improves Growth Performance of Weaned Piglets. PMID: 34205785
Sequence polymorphisms and antibody binding to the group 2 dust mite allergens. PMID: 11306927
A rapid subtractive immunization method to prepare discriminatory monoclonal antibodies for food E. coli O157:H7 contamination. PMID: 22347466
Monoclonal antibodies against Rh and Rh related antigens. PMID: 1709670
Development of a neutralizing mouse-pig chimeric antibody with therapeutic potential against Haemophilus parasuis in Pichia pastoris. PMID: 24698098
Effect of cholecystokinin on experimental neuronal aging. PMID: 15641144
Selecting fermentation products for food waste valorisation with HRT and OLR as the key operational parameters. PMID: 33932853
Splittings of d8 configurations of late-transition metals with EOM-DIP-CCSD and FSCCSD methods. PMID: 32268764
Evidence for Complex Formation of the Bacillus cereus Haemolysin BL Components in Solution. PMID: 28926954
Generation of monoclonal antibodies reactive with nuclear proteins of human primary breast tumors. PMID: 3276634
Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. PMID: 11927939
[Clinical Efficacy of Low-Dose Bortezomib-Based Triple Combination Therapy in the Treatment of Elderly Multiple Myeloma]. PMID: 32319392
Distribution of CRISPR in Escherichia coli Isolated from Bulk Tank Milk and Its Potential Relationship with Virulence. PMID: 35203211
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion. PMID: 16432173
Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens. PMID: 7621591
Excretion and toxicity evaluation of 131I-Sennoside A as a necrosis-avid agent. PMID: 27830982
Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137. PMID: 15051893
Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2. PMID: 18593942
Development of clinical phenotypes and biological profiles via proteomic analysis of trauma patients. PMID: 35933364
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity. PMID: 30442944
Novel monoclonal antibodies against Fiber-1 of duck adenovirus 3 and their B cell epitopes. PMID: 36311658
Development and application of a colloidal gold test strip for the rapid detection of the infectious laryngotracheitis virus. PMID: 32359575
Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. PMID: 7528571
Development of Monoclonal Antibodies and Characterization of an ELISA Platform Against Kallikrein-Related Peptidase 6 as a Tumor Biomarker. PMID: 26492623
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. PMID: 34785638
Phytochemicals: Alternative for Infertility Treatment and Associated Conditions. PMID: 37215366
Upregulation of nucleobindin expression in human-activated lymphocytes and non-Hodgkin's lymphoma. PMID: 9589460
Identification of the immunogenic outer membrane protein A antigen of Haemophilus parasuis by a proteomics approach and passive immunization with monoclonal antibodies in mice. PMID: 21832103
Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. PMID: 7553723
Coherent Dynamic Nuclear Polarization using Chirped Pulses. PMID: 37184391
Rh-related antigen CD47 is the signal-transducer integrin-associated protein. PMID: 8294396
Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein. PMID: 12853385
Expression of 1D8--a novel non-sialylated B-cell-associated carbohydrate epitope in lymphoproliferative disorders. PMID: 7996874
B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. PMID: 18790673
Purification and characterization of 66-kDa glycoprotein from human breast carcinoma. PMID: 17640306
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR. PMID: 33488625
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. PMID: 16818658
Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment. PMID: 17332366
Monoclonal antibody 1D8 detects an activation-related molecule on human B lymphocytes and on a minor T-lymphocyte subpopulation. PMID: 7528720
Efficient purification of GP-1D8 glycoprotein from human breast carcinoma tissue by immunoaffinity chromatography. PMID: 18800296
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. PMID: 34172583
For research use only. Not for human or drug use.
